INACTIVATION OF HUMAN ERYTHROCYTE AGGLUTINOGENS M AND N BY INFLUENZA VIRUSES AND RECEPTOR-DESTROYING ENZYME.
作者信息
Springer G F, Ansell N J
机构信息
IMMUNOCHEMISTRY SECTION, WILLIAM PEPPER LABORATORY OF CLINICAL MEDICINE, UNIVERSITY OF PENNSYLVANIA, PHILADELPHIA, PENNSYLVANIA.
出版信息
Proc Natl Acad Sci U S A. 1958 Feb;44(2):182-9. doi: 10.1073/pnas.44.2.182.
Abstract
摘要
相似文献
1
INACTIVATION OF HUMAN ERYTHROCYTE AGGLUTINOGENS M AND N BY INFLUENZA VIRUSES AND RECEPTOR-DESTROYING ENZYME.
Proc Natl Acad Sci U S A. 1958 Feb;44(2):182-9. doi: 10.1073/pnas.44.2.182.
2
3
Inactivation of inhibitors by the receptor-destroying enzyme of influenza C virus.
J Gen Virol. 1997 Mar;78 ( Pt 3):567-70. doi: 10.1099/0022-1317-78-3-567.
4
Electrophoretic studies of virus-red cell interaction: additive effect of viruses of the influenza group and the receptor-destroying enzyme of V. cholerae.
Br J Exp Pathol. 1950 Jun;31(3):275-84.
5
The receptor-destroying enzyme of influenza C virus is required for entry into target cells.
Virology. 1993 Feb;192(2):679-82. doi: 10.1006/viro.1993.1087.
6
7
8
[The nature of the influenza C virus receptor and the specificity of the receptor-destroying enzyme].
Vopr Virusol. 1987 May-Jun;32(3):300-3.
9
Functional balance between neuraminidase and haemagglutinin in influenza viruses.
Clin Microbiol Infect. 2016 Dec;22(12):975-983. doi: 10.1016/j.cmi.2016.07.007. Epub 2016 Jul 15.
10
[Research on M & N agglutinogens in platelets by means of the thrombocyte-erythrocyte mixed agglutination method].
Arch Maragliano Patol Clin. 1957 Aug;13(4):875-8.
引用本文的文献
1
The use of sialidase therapy for respiratory viral infections.
Antiviral Res. 2013 Jun;98(3):401-9. doi: 10.1016/j.antiviral.2013.04.012. Epub 2013 Apr 17.
2
Diagnostics and surveillance for Swine influenza.
Curr Top Microbiol Immunol. 2013;370:85-112. doi: 10.1007/82_2012_220.
3
BLOOD GROUP ACTIVITY OF GRAM-NEGATIVE BACTERIA.
J Exp Med. 1961 Jun 1;113(6):1077-93. doi: 10.1084/jem.113.6.1077.
4
Specific inhibition of endotoxin coating of red cells by a human erythrocyte membrane component.
Infect Immun. 1970 Jan;1(1):98-108. doi: 10.1128/iai.1.1.98-108.1970.
5
[On relations of bacterial antigens and blood group specific substances in man and animal].
Z Hyg Infektionskr. 1959;146:58-61.
6
AN ANOMALY OF INHERITANCE IN THE MNSS BLOOD GROUPS.
Am J Hum Genet. 1965 Jan;17(1):9-13.
7
Enzymatic and nonezymatic alterations of erythrocyte surface antigens.
Bacteriol Rev. 1963 Jun;27(2):191-227. doi: 10.1128/br.27.2.191-227.1963.
8
Preparation of an inhibitor of viral hemagglutination from human erythrocytes.
J Exp Med. 1961 Jan 1;113(1):37-45. doi: 10.1084/jem.113.1.37.
9
[On the serology of stained blood corpuscles].
Blut. 1960 Sep;6:193-202. doi: 10.1007/BF01630002.
10
Specific role of T and Tn tumor-associated antigens in adhesion between a human breast carcinoma cell line and a normal human breast epithelial cell line.
Jpn J Cancer Res. 1999 Mar;90(3):326-32. doi: 10.1111/j.1349-7006.1999.tb00751.x.
本文引用的文献
1
The Proteolytic Enzyme Test for Detecting Incomplete Antibodies.
J Clin Pathol. 1951 May;4(2):189-99. doi: 10.1136/jcp.4.2.189.
2
The identification of hemagglutinins with red cells altered with trypsin.
Trans N Y Acad Sci. 1951 Apr;13(6):213-20. doi: 10.1111/j.2164-0947.1951.tb00042.x.
3
Specific release of heterogenetic mononucleosis receptor by influenza viruses, receptor destroying enzyme and plant proteases.
Proc Soc Exp Biol Med. 1957 Oct;96(1):103-7. doi: 10.3181/00379727-96-23405.
4
Enzymes of Clostridium tertium: effects on blood group and virus receptor substances.
J Bacteriol. 1957 Sep;74(3):365-76. doi: 10.1128/jb.74.3.365-376.1957.
5
Virus enzymes and virus templates.
Physiol Rev. 1957 Jan;37(1):66-83. doi: 10.1152/physrev.1957.37.1.66.
6
Blood group mucoids: their distribution and growth-promoting properties for Lactobacillus bifidus var. Penn.
J Lab Clin Med. 1954 Apr;43(4):532-42.
7
Inactivation of the H receptors on human erythrocytes by an enzyme obtained from Trichomonas foetus.
Br J Exp Pathol. 1954 Apr;35(2):181-90.
Zotero 插件